Table 2 SNPs associated with telomere length.

From: Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms

SNP

Gene

Chr

Position

EA

OA

EAF

β (SE)

Base pairsa

Discovery Pvalue

Discovery study

rs412658

ZNF676

19

22,359,440

T

C

0.35

0.086 (0.010)

103.2

1.00 × 10−8

Mangino34

rs8105767

ZNF208

19

22,032,639

G

A

0.28

0.064 (0.011)

76.8

1.11 × 10−9

Codd35

rs3027234

CTC1

17

8,232,774

C

T

0.78

0.103 (0.012)

123.6

2.00 × 10−8

Mangino34

rs9420907

OBFC1

10

103,916,707

C

A

0.13

0.142 (0.014)

170.4

7.00 × 10−11

Levy45

rs755017

ZBTB46

20

62,421,622

G

A

0.12

0.019 (0.013)

22.8

6.71 × 10−9

Codd35

rs6028466

DHX35

20

39,500,359

A

G

0.07

0.058 (0.013)

69.6

2.57 × 10−8

Haycock23

rs7675998

NAF1

4

163,086,668

G

A

0.76

0.048 (0.012)

57.6

4.35 × 10−16

Codd35

rs10936599

TERC

3

169,774,313

C

T

0.76

0.100 (0.011)

120

3.00 × 10−31

Codd35

rs11125529

ACYP2

2

54,248,729

A

C

0.11

0.065 (0.012)

78

8.00 × 10−10

Codd35

rs6772228

PXK

3

58,390,292

T

A

0.96

0.041 (0.014)

49.2

3.91 × 10−10

Haycock23

rs2736100

TERT

5

1,286,401

C

A

0.5

0.085 (0.013)

102

4.38 × 10−19

Codd35

  1. EA effect allele, OA other allele, EAF effect allele frequency in the Caucasian population, β (SE) estimate of telomere length variation for each copy of EA.
  2. aBase pairs: estimate in base pairs of telomere length variation for each copy of EA, as described in Codd35.